Governor Requests the Agency for Health Care Administration to Inspect Florida's VA Hospitals Print E-mail
Written by George F. Indest III, JD, MPA, LLM, Board Certified in Health Law   
Friday, 18 April 2014 11:10

In response to recent deaths at Veterans Affairs (VA) hospitals throughout Florida and the rest of the nation, on April 1, 2014, Governor Rick Scott wrote a letter to the Florida Agency for Health Care Administration (AHCA) requesting the agency begin inspecting VA hospitals in the Sunshine Health Network.

Read More>>       Related Article HERE 

Source: The Health Law Firm Blog  

Last Updated on Friday, 18 April 2014 12:54
H.R. 4302: Duct tape, delays and decision support Print E-mail
Written by Matt Hawkins, MD | Fierce Medical Imaging   
Friday, 11 April 2014 09:46

A permanent fix to the sustainable growth rate formula eluded Congress again--stunning, I know. Another year of SGR duct tape. And ICD-10 was laughably delayed for yet another year. (How many ICD-11 jokes have you heard over the last couple of weeks?) This kind of partisan-driven politicking escalates the apathy that many physicians already have for Washington. But maybe that's their objective.

However, H.R. 4302 (the Protecting Access to Medicare Act of 2014), which was passed by Congress just last week, contained some language/mandates that should be considered major victories for imaging, patients, and anyone concerned with utilization of imaging services.

Read More>>

Last Updated on Friday, 11 April 2014 09:50
HHS and GAO Reports Highlight Need to Address Drug Shortages Print E-mail
Written by   
Monday, 07 April 2014 08:16

Two recently released reports from the U.S. Department of Health and Human Services (HHS) and the U.S. Government Accountability Office, respectively, focus on the impact of prescription drug shortages, their potential causes and the role that HHS, particularly the Food and Drug Administration, plays in identifying, tracking and alleviating these problems.

In recent years, an increasing number of drug shortages have threatened public health by reducing-if not eliminating-patient access to critical pharmaceuticals. As such, drug shortages have been the subject of considerable federal activity, including an October 2011 Executive Order that directed the U.S. Food and Drug Administration (FDA) to "take steps that will help to prevent and reduce current and future disruptions in the supply of lifesaving medicines" (e.g., requiring broader reporting of manufacturing discontinuances and expediting regulatory reviews), and a December 2011 interim final rule issued by the FDA that amended the FDA's early notification requirements.

Read More>>

Sponsor Showcase Print E-mail
Written by Sponsor   
Monday, 14 April 2014 00:00
gsk fhi-2012-ad v3
Last Updated on Monday, 14 April 2014 08:04

Website design, development, and hosting provided by